 DURHAM, N.C., Aug. 11, 2021 GLOBE NEWSWIRE -- Heat Biologics, Inc. Heat NASDAQ: HTBX, a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today provided financial, clinical and operational updates for the second quarter ended June 30, 2021. 